Work

Antitumor immune response elicited by M2 TAM-specific DDS via C-type lectin CD209b using cholesteryl pullulan nanogel as a protein drug carrier

Year: 2025

Type: article

Source: Biomaterials Science

DOI: 10.1039/d5bm00342c

Authors: Takaaki Nakatsukasa, Daisuke Muraoka, Situo Deng, Kiyoshi Yasui, Shin-ichi Sawada, Asako Shimoda, Hirokazu Matsushita, Keitaro Matsumoto, Takeshi Nagayasu, Naozumi Harada, Kazunari Akiyoshi, Hiroaki Ikeda

Institutions: Nagasaki University, Aichi Cancer Center, Aichi Cancer Center Research Institute, Chiba University, Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Kyoto University, The Hakubi Center for Advanced Research, Kyoto University

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science

Awards: T cell therapy that overcome tumor heterogeneity by expansion of T cell repertoire and immune-related cell death effect., G4040768115, G4054678481, Development of cancer immunotherapy for heterogenous tumor including multiple immunogenic tumors., Development of immune cell therapy of refractory tumor utilizing allogeneic designer cells, Development of novel transplantation therapy using designer cells with immune evasion mechanisms, Cancer immunotherapy that overcomes tumor heterogeneity by a compound enhancing bystander effect., Development of Novel Adoptive Cell Therapy for Tumors Containing antigen loss variants cells

OpenAlex ID: W4408523950

FWCI: 0.701

Cites: 60

Cited by: 4

Related to: 10